Merck’s $8 billion cancer vaccine faces first U.S. jury trial


GettyImages 1251776810 e1738017238996
Jurors will weigh whether Merck withheld side-effect reports from drug regulators and launched misleading marketing campaigns to turn the drug into a blockbuster product. Read More

Leave a Comment

You cannot copy content of this page